Home > Clinical Trials
Check All Search

Saved trials

RECRUITING
NCT07030569
RADIomics to Predict HER2 Status And T-DXd Efficacy in Metastatic Breast Cancer: the RADIOSPHER2 Study
500 Enrollment(s)
1 Study location(s)
OBSERVATIONAL (None)
Radiomic


Radiomics


Breast Cancer Metastatic


Breast Cancer Stage IV


Breast Carcinoma


Breast Neoplasms


Breast Cancer


Breast Cancer With Bone Metastasis


Breast Cancer With Metastatic Bone Disease


Trastuzumab


HER2


HER2 + Breast Cancer


HER2 Positive Breast Carcinoma


HER2-positive Breast Cancer


Her2/Neu Positive Advanced Solid Tumors


HER2/Neu-positive Breast Cancer
RECRUITING
NCT06832202
A Phase II Study of HLX22 in Combination With Trastuzumab Deruxtecan in HER2-low, Hormone Receptor Positive Locally Advanced or Metastatic Breast Cancer Patients
50 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE2)
HER2-low Hormone Receptor Positive Breast Cancer
COMPLETED
NCT04132960
Study of DS-8201a, an Antibody Drug Conjugate for Advanced Breast Cancer Patients, With Biomarkers Analysis
186 Enrollment(s)
15 Study location(s)
INTERVENTIONAL (PHASE2)
Breast Tumors
TERMINATED
NCT03505710
DS-8201a in Human Epidermal Growth Factor Receptor 2 (HER2)-Expressing or -Mutated Non-Small Cell Lung Cancer
181 Enrollment(s)
21 Study location(s)
INTERVENTIONAL (PHASE2)
Non-Small Cell Lung Cancer
TERMINATED
NCT05066789
CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4
100 Enrollment(s)
1 Study location(s)
INTERVENTIONAL (PHASE4)
Coronary Artery Disease
ACTIVE_NOT_RECRUITING
NCT03129490
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
11,000 Enrollment(s)
38 Study location(s)
INTERVENTIONAL (PHASE4)
Atrial Fibrillation


Atrial Flutter
ACTIVE_NOT_RECRUITING
NCT03129555
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
5,000 Enrollment(s)
26 Study location(s)
INTERVENTIONAL (PHASE4)
Deep Vein Thrombosis


Pulmonary Embolism
RECRUITING
NCT06957366
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure
920 Enrollment(s)
14 Study location(s)
INTERVENTIONAL (NA)
Atrial Fibrillation (AF)


VTE